题名 | Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats |
作者 | |
发表日期 | 2012-01 |
发表期刊 | MOLECULAR AND CELLULAR BIOCHEMISTRY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Phosphatidylinositol 3-kinase Asthma Nitric oxide Inducible nitric oxide synthase Airway inflammation |
其他关键词 | ALLERGIC AIRWAY INFLAMMATION ; FACTOR-KAPPA-B ; PHOSPHOINOSITIDE 3-KINASE ; HYPERRESPONSIVENESS ; ACTIVATION ; WORTMANNIN ; RESPONSES ; MICE ; AKT |
摘要 | Inducible nitric oxide synthase (iNOS) is known to produce nitric oxide (NO), which is a main contributor to asthmatic airway inflammation. Recent studies have shown that phosphatidylinositol 3-kinase (PI3K) is ubiquitously expressed in airway epithelial cells and its inhibition could relieve airway inflammation and hyperresponsiveness. This study aimed to explore the interaction of PI3K and NO signaling in allergic asthma. We investigated the effects of PI3K inhibitor wortmannin on iNOS expression in bronchiole epithelial cells and NO, IL-4 and IFN-gamma levels in lung tissues of asthmatic rat model, which was prepared by 10% OVA solution sensitization and 1% OVA aerosol challenge. Our results showed that the ratio of eosinophils to total cells in BALF, PI3K activity, NO and IL-4 levels in lung tissues was increased after OVA sensitization and challenge, but then was attenuated by the administration of wortmannin. In contrast, IFN-gamma level in lung tissues was decreased after OVA sensitization and challenge and increased after the administration of wortmannin. The expression of iNOS protein in bronchiole epithelial cells, iNOS mRNA level and iNOS activity in lung tissues was markedly upregulated after OVA sensitization and challenge, but the upregulation was significantly antagonized by wortmannin. Taken together, these data provide evidence that PI3K functions upstream to modulate iNOS/NO signaling, which then promotes the development of airway inflammation in asthmatic animal model. PI3K inhibitor wortmannin could lead to reduced iNOS expression and NO production, therefore inhibiting airway inflammatory responses. |
资助项目 | Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Y2080466] |
出版者 | SPRINGER |
出版地 | DORDRECHT |
ISSN | 0300-8177 |
EISSN | 1573-4919 |
卷号 | 359期号:1-2页码:293-299 |
DOI | 10.1007/s11010-011-1023-y |
页数 | 7 |
WOS类目 | Cell Biology |
WOS研究方向 | Cell Biology |
WOS记录号 | WOS:000297174700030 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 21847581 |
SCOPUSEID | 2-s2.0-83555164967 |
通讯作者地址 | [Xu, Zhengjie]Wenzhou Med Coll, Dept Pathophysiol, Wenzhou 325027, Zhejiang, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/1663 |
专题 | 基础医学院(机能实验教学中心)_病理学与病理生理学系 附属第二医院_呼吸内科 检验医学院(生命科学学院、生物学实验教学中心)_生物学实验教学中心 |
通讯作者 | Xu, Zhengjie |
作者单位 | 1.Wenzhou Med Coll, Dept Pathophysiol, Wenzhou 325027, Zhejiang, Peoples R China; 2.Wenzhou Med Coll, Dept Resp Med, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; 3.Wenzhou Med Coll, Ctr Lab Biol, Wenzhou 325027, Zhejiang, Peoples R China |
第一作者单位 | 附属第二医院_呼吸内科 |
通讯作者单位 | 基础医学院(机能实验教学中心)_病理学与病理生理学系 |
第一作者的第一单位 | 附属第二医院_呼吸内科 |
推荐引用方式 GB/T 7714 | Xia, Xiaodong,Hu, Xiaoguang,Xu, Hui,et al. Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats[J]. MOLECULAR AND CELLULAR BIOCHEMISTRY,2012,359(1-2):293-299. |
APA | Xia, Xiaodong., Hu, Xiaoguang., Xu, Hui., Wu, Liqin., Dai, Yuanrong., ... & Xu, Zhengjie. (2012). Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats. MOLECULAR AND CELLULAR BIOCHEMISTRY, 359(1-2), 293-299. |
MLA | Xia, Xiaodong,et al."Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats".MOLECULAR AND CELLULAR BIOCHEMISTRY 359.1-2(2012):293-299. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论